Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Hashimoto

Showing results (321-330 of 330) with videos related to

Pageof 33
Sort By:
You have reached the last page of results.This site can display upto 330 results.
The Prostate|September 22, 2021
Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA levelTohru Yoneyama, Hayato Yamamoto, Mihoko Sutoh Yoneyama, et al.
Cancer Medicine|November 11, 2024
Darolutamide in Japanese patients with metastatic hormone-sensitive prostate cancer: Phase 3 ARASENS subgroup analysisMotohide Uemura, Hiroaki Kikukawa, Yasuhiro Hashimoto, et al.
Metabolites|September 26, 2021
Transferrin Biosynthesized in the Brain Is a Novel Biomarker for Alzheimer's DiseaseKyoka Hoshi, Hiromi Ito, Eriko Abe, et al.
Oncotarget|November 16, 2017
Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinomaHirotake Kodama, Shingo Hatakeyama, Naoki Fujita, et al.
BJUI Compass|April 27, 2022
Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancerNaoki Terada, Takashi Mizowaki, Toshihiro Saito, et al.
Cancer Science|January 4, 2026
Longitudinal Impact of Urinary Diversion on Health-Related Quality of Life After Radical Cystectomy: A Multicenter Study in JapanShuhei Yamada, Miho Sato, Takahiro Osawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 28, 2026
Validation of the 7-Item Quality of Life Disease-Specific Impact Scale in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Cross-Sectional StudySayaka Shimizu, Takahiro Osawa, Miho Sato, et al.
International Journal of Clinical Oncology|December 17, 2024
Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancerTokiyoshi Tanegashima, Masaki Shiota, Naoki Terada, et al.
Cancer Science|June 19, 2021
Novel metastatic burden-stratified risk model in de novo metastatic hormone-sensitive prostate cancerMasaki Shiota, Naoki Terada, Hiroshi Kitamura, et al.
Cancer Science|November 7, 2020
Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patientsMasaki Shiota, Naoki Terada, Toshihiro Saito, et al.
Pageof 33

Showing results (321-330 of 330) with videos related to

Sort By:
Pageof 33
You have reached the last page of results.This site can display upto 330 results.
The Prostate|September 22, 2021
Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA levelTohru Yoneyama, Hayato Yamamoto, Mihoko Sutoh Yoneyama, et al.
Cancer Medicine|November 11, 2024
Darolutamide in Japanese patients with metastatic hormone-sensitive prostate cancer: Phase 3 ARASENS subgroup analysisMotohide Uemura, Hiroaki Kikukawa, Yasuhiro Hashimoto, et al.
Metabolites|September 26, 2021
Transferrin Biosynthesized in the Brain Is a Novel Biomarker for Alzheimer's DiseaseKyoka Hoshi, Hiromi Ito, Eriko Abe, et al.
Oncotarget|November 16, 2017
Preoperative chronic kidney disease predicts poor oncological outcomes after radical nephroureterectomy in patients with upper urinary tract urothelial carcinomaHirotake Kodama, Shingo Hatakeyama, Naoki Fujita, et al.
BJUI Compass|April 27, 2022
Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancerNaoki Terada, Takashi Mizowaki, Toshihiro Saito, et al.
Cancer Science|January 4, 2026
Longitudinal Impact of Urinary Diversion on Health-Related Quality of Life After Radical Cystectomy: A Multicenter Study in JapanShuhei Yamada, Miho Sato, Takahiro Osawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 28, 2026
Validation of the 7-Item Quality of Life Disease-Specific Impact Scale in Patients Undergoing Radical Cystectomy for Bladder Cancer: A Cross-Sectional StudySayaka Shimizu, Takahiro Osawa, Miho Sato, et al.
International Journal of Clinical Oncology|December 17, 2024
Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancerTokiyoshi Tanegashima, Masaki Shiota, Naoki Terada, et al.
Cancer Science|June 19, 2021
Novel metastatic burden-stratified risk model in de novo metastatic hormone-sensitive prostate cancerMasaki Shiota, Naoki Terada, Hiroshi Kitamura, et al.
Cancer Science|November 7, 2020
Differential prognostic factors in low- and high-burden de novo metastatic hormone-sensitive prostate cancer patientsMasaki Shiota, Naoki Terada, Toshihiro Saito, et al.
Pageof 33